Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jaktinib in COVID-19 Pneumonia
NCT05672888Phase 2Unknown
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Mar 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
A Phase 2 trial of jaktinib in COVID-19 pneumonia, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Status: unknown.
02
Drugs
jaktinib
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT05672888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05672888.